Blue Moon Metals (BMM) is the quiet second half of Matt McCall’s Edison Prophecy pitch. The headline act is a small optical-materials company trying to replace germanium in thermal-imaging lenses, but Blue Moon is the freebie he tacks on as the domestic supplier of the metals underneath the story. It trades around $3.09 a share with a market cap near $334 million, down about 14.1% from the $3.59 figure the teaser leaned on. That drop is not the most interesting number here. The premium purchase last month is.
Who is Matt McCall, and why this pitch
McCall edits Early Opportunities at Monument Traders Alliance. Before that he ran MegaTrend Investor under Stansberry and Investment Opportunities at InvestorPlace, and his most cited past teaser call was pointing readers at NVIDIA back in 2017. That record is why his picks get attention, and it is also why we treat the Edison Prophecy with respect rather than a shrug.
The pitch leans on a 1915 Thomas Edison prophecy that the future soldier would be a machinist who fights with machines. McCall uses that century-old line to frame a modern argument: the Pentagon is trying to build a defense supply chain that does not depend on Chinese critical minerals, and small companies sitting on domestic sources of those materials are positioned to benefit. Blue Moon is the gallium chapter of that argument, and it is a genuinely different bet from the germanium-free lens pick that anchors the promo.
What Blue Moon Metals actually owns
The centerpiece is the Apex project in Utah, a germanium-gallium-copper deposit built around a historic US mine. That mine shut down in 1987 because prices no longer justified running it, and the United States has produced essentially no gallium domestically since. That is the scarcity hook holding the whole story up.
Blue Moon bought Apex from Teck Resources, and Teck took shares instead of cash. Our teardown reads that two ways. A seller willing to be paid in a junior miner’s stock is a soft signal of confidence in the asset, since Teck chose to keep exposure to the story rather than take cash and walk away. But it also means Teck’s interests and Blue Moon’s are not fully aligned in the usual buyer-seller sense. Both readings are fair.
The deposit carries germanium and copper alongside gallium, which is a subtle wrinkle. The headline pick in this same promo is a company trying to make germanium obsolete in thermal lenses. Gallium is the metal Blue Moon is actually being pitched on, the one no American mine has produced since 1987. For how those two metals differ, the gallium explainer lays it out in detail.
The premium purchase, explained
Last month a Pentagon-backed buyer agreed to buy Blue Moon shares at nearly a 32% premium to the market price. That is a genuine signal, and our teardown treats it as meaningful but narrow. A premium share purchase is a single transaction. It is not a supply agreement, not a commitment to fund construction at Apex, and not a contract to buy gallium. What it shows is that defense-adjacent capital is paying attention to a domestic gallium story and wants exposure to it. It does not, by itself, move a mine into production.
The broader logic is sound. Gallium sits inside LED bulbs, smartphone signals, and Navy radar, and it is famously “the metal that melts in your hand” because it melts near 85 degrees Fahrenheit. A metal that useful, with essentially zero US production, is exactly the kind of supply gap a defense procurement office wants to close. China’s export controls give that gap an urgency that has nothing to do with marketing.
The honest caveats
Blue Moon is an exploration-stage company, not a producer. Apex is not in operation, and restarting a mine shut since 1987 is a multi-year, capital-intensive job with permitting, engineering, and financing risk at every step. The premium purchase helps, but it is the first inning of a long game.
The company also carries a basket of other properties: a polymetallic zinc-gold-silver-copper deposit in California and the Nussir copper project in Norway. Diversification can sound reassuring, but at this size it mostly means management attention and capital get spread across several early-stage assets, none of which is generating meaningful cash flow yet.
The stock has already slipped below its tease price, which suggests the market is pricing in that execution risk rather than cheering the headline. We would treat this as a story worth understanding, not a ticker to chase on a deadline. If you want the full picture on the primary pick sitting next to this gallium freebie, the LightPath pick covers the germanium-free lens thesis.
How the China timeline shapes the trade
China’s export controls are the backdrop behind this story. The United States has deadlines written into law to push Chinese germanium out of the defense supply chain by December 2027 and Chinese optics out by 2030, and a separate one-year export-control hold on germanium and gallium is scheduled to expire on November 27, 2026. Our teardown treats that November date as a negotiation artifact rather than a binary cliff, because export controls get extended and reshaped all the time.
The direction of travel is the part that matters. A Pentagon that wants domestic critical minerals is not going to stop wanting them after a single deadline passes. That is the patient case for Blue Moon: the trend favors a domestic gallium source even if the timeline stays uncertain, and the premium purchase is one early sign that the trend is real rather than theoretical.
Ready to see the research? Click here to access Matt McCall’s report.
NewsletterVetter is an independent publication. We receive compensation from some of the services we review through affiliate links. Nothing on this site is investment advice. Always do your own research.